The US Patent & Trade Office on March 7, 2013 granted GW Pharma a medical patent covering all plant-based phytocannabinoids for use in the treatment and prevention of basically all forms of human cancer.
Entitled: PHYTOCANNABINOIDS IN THE TREATMENT OF CANCER United States Patent Application # 20130059018 Assignee: GW Pharma Publication Date: 03/07/2013 Filing Date: 03/11/2011
All phytocannabinoids? As in the plural? As in covering every chemical this plant makes and its use in the treatment of human cancer?
The back story: On 1/17/2013, the National Cancer Institute updated its Cannabis and Cannabinoids PDQ® webpage with the following new cannabis and cancer information, which just by coincidence supports the new GW Pharma pre-approved patent and lays the groundwork for GW Pharma’s future new breakout marijuana-based cancer drugs.
From Cannabis and Cannabinoids (PDQ®) Last Modified: 01/17/2013
“Cannabinoids may cause antitumor effects by various mechanisms, including induction of cell death, inhibition of cell growth, and inhibition of tumor angiogenesis invasion and metastasis.”
“One review summarizes the molecular mechanisms of action of cannabinoids as antitumor agents. Cannabinoids appear to kill tumor cells but do not affect their non-transformed counterparts and may even protect them from cell death.”
“These compounds have been shown to induce apoptosis in glioma cells (a type of brain cancer) in culture and induce regression of glioma tumors in mice and rats. Cannabinoids protect normal glial cells of astroglial and oligodendroglial lineages from apoptosis mediated by the CB1 receptor.”
Read: Cannabinoids from plant sources cause immortalized cancer cells to die, stops them from growing and shuts down their needed blood supply, all while not harming healthy cells, unlike chemotherapy and radiation.
More back story information: Below is the same type of National Cancer Institute Cannabis and Cannabinoids PDQ® update that appeared on March 17, 2011 but was censored and removed in only 11 days: that was two years ago.
“The potential effects of medicinal cannabis for people living with cancer include antiemetic effects, appetite stimulation, pain relief, and improved sleep. In the practice of integrative oncology the health care provider may recommend medicinal cannabis not only for symptom management but also for its possible direct anti-tumor effect.”
“The NCI report examined whether patients who smoke marijuana rather than ingesting it orally are exposed to a higher risk of lung and certain digestive system cancers…”
According to the government, 19 studies “failed to demonstrate statistically significant associations between marijuana inhalation and lung cancer.” The report also identified a separate study of 611 lung cancer patients that showed marijuana was “not associated with an increased risk of lung cancer or other upper aero digestive tract cancers and found no positive associations with any cancer type.”
In its report, the National Cancer Institute also identified a “study of intratumoral injection of delta-9-THC in patients with recurrent glioblastoma [brain cancer] that showed tumor reduction in the test participants.”
In addition to anti-cancer properties, separate research reported marijuana appears to have “profound nerve-protective and brain-enhancing properties that could potentially treat many neurodegenerative disorders.”
Dr. Donald Tashkin, UCLA: “It turned out that increased marijuana use did not result in higher rates of lung and pharyngeal cancer, whereas tobacco smokers were at greater risk the more they smoked. Tobacco smokers who also smoked marijuana were at slightly lower risk of getting lung cancer than tobacco-only smokers.” [NORML ZA]
Furthermore all of the above information is in full agreement with studies conducted by Dr. Donald Tashkin, UCLA.
“This invention relates to the use of phytocannabinoids, either in an isolated form or in the form of a botanical drug substance (isn’t that cannabis?) In the treatment of cancer. Preferably the cancer to be treated is cancer of the prostate, cancer of the breast or cancer of the colon.”
This is what they grow, and the starting point from where they extract their patented medicines. This eye candy photo was taken directly from the GW Pharma website; you can even zoom in on it to examine the quality! Here, give it a try! http://www.gwpharm.com/library.aspx
“Researchers however have discovered that some cannabinoids, including THC and cannabidiol (CBD) are able to promote the re-emergence of apoptosis (the signal for a cell to die) so that some tumors will heed the signals, stop dividing, and die.”
“Another method by which tumors grow is by ensuring that they are nourished: they send out signals to promote angiogenesis, the growth of new blood vessels. Cannabinoids may turn off these signals as well.”
“In summary these data demonstrate the protective effects of phytocannabinoids in the PREVENTION of colon cancer. Of significance is the phytocannabinoids CBG which exerts a strong protective effect against colon cancer particularly when it is in an isolated form.”
GW’s grow house operations. They don’t sell marijuana, they sell medicine. See the difference?
Pay no attention to the fact that cannabis use predates human civilization. How do you make it illegal for people but not corporations? Equal treatment under the law is for people and access to medicine.
Patenting cannabis is like patenting corn and all the products it makes, and then telling me I can’t grow corn in my backyard. How do you patent nature, restrict people’s access to it and then charge them to use it while you are making a big profit?
“Despite the Federal government sanctioned and authorized NCI report, Pappas said Congress and the Obama Administration have continued to thwart marijuana research. In an announced effort to displace state medical marijuana laws, the Office of National Drug Control Policy described ‘medical’ marijuana as a ‘myth’ fueling ‘troubling misconceptions’ in documents found on its website.
The Federal government appears to be focused on creating more chemical drugs, many of which are the subject of various attorney television commercials seeking out those adversely impacted by those drugs.”
Here comes the big payday that you’re not going to be part of. How much will one month of Sativex wind up costing? My lowball guess is north of $2000/month X 12 =$24,000 per patient vs. The average monthly cost of cannabis use per patient at about $200-400 per month?
I propose the US government nationalize this new fledgling marijuana industry as a cooperative nationwide network of American people, and not of corporations.
This should be reparation to the people, to try to heal the 75-year war we have waged on ourselves out of ignorance.
How about we, the American people, win for once?
GW Pharma is really part of a conglomeration of international pharmaceutical corporations that just patented a plant you can grow in your backyard and will control its use in cancer treatment. I’m sure they have our best interests at heart.
Mr. Worth Repeating: former NYPD cop, former high school health teacher, the unstoppable Ron Marczyk, R.N., Toke Signals columnist
Editor’s note: Ron Marczyk is a retired high school health eduation teacher who taught Wellness and Disease Prevention, Drug and Sex Ed, and AIDS education to teens aged 13-17.
He also taught a high school International Baccalaureate psychology course. He taught in a New York City public school as a Drug Prevention Specialist. He is a Registered Nurse with six years of ER/Critical Care experience in NYC hospitals, earned an M.S. in cardiac rehabilitation and exercise physiology, and worked as a New York City police officer for two years.
Currently he is focused on how evolutionary psychology explains human behavior.